Clinical solutions

Integrated AI pathology – fast, precise, proven

Aiforia® Clinical Suites deliver integrated workflows to enhance efficiency, consistency, and diagnostic accuracy. Users can leverage AI-driven image analysis, standardized scoring, and automated reporting to achieve objective, quantitative, and explainable results. Proven in clinical settings worldwide, Aiforia integrates into existing workflows with flexible deployment options, empowering pathology laboratories to handle the growing case volumes.

Request a demo View AI solutions

 

Breast Cancer Suite Colon Suite Gastric Suite Lung Cancer Suite Lymph Node Metastasis Prostate Cancer Suite
Select suite

Aiforia® Breast Cancer Suite

Aiforia® Breast Cancer Suite consists of AI models with an optimized interactive user interface that supports pathologists in the histological grading of breast cancer and in the assessment of breast cancer IHC markers.

  • Aiforia® Breast Cancer Grading
  • Aiforia® Breast Cancer ER
  • Aiforia® Breast Cancer PR
  • Aiforia® Breast Cancer HER2
  • Aiforia® Breast Cancer Ki67
  • Aiforia® Lymph Node Metastasis

All AI models in Aiforia® Breast Cancer Suite are CE-IVD marked for diagnostic use in EU and EEA countries and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas.

Learn more

Aiforia® Colon Suite

Aiforia® Colorectal Cancer QuantCRC identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for treatment decisions. The AI model was developed and validated in collaboration with the Mayo Clinic.

Aiforia® Lymph Node Metastasis supports the detection and quantification of metastases of colorectal cancer in lymph nodes from whole slide images. The AI model was developed in collaboration with the University of Bern.

  • Aiforia® Colorectal Cancer QuantCRC
  • Aiforia® Lymph Node Metastasis*

*CE-IVD marked for diagnostic use in EU and EEA countries. All other AI models are currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas.

Learn more

Aiforia® Gastric Cancer Suite

Supports the detection of gastric cancer and Helicobacter pylori in whole slide images (WSI) of H&E-stained FFPE gastric tissue.

Aiforia® Gastric Cancer is currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas.

Aiforia® Lung Cancer Suite

Overcome the challenges of subjective and time-consuming manual PD-L1 scoring in lung cancer – Aiforia® Lung Cancer Suite can reduce errors and help standardize scoring by providing AI-driven PD-L1 assessments that are objective and reproducible. 

  • Aiforia® Lung Cancer PD-L1*

*CE-IVD marked for diagnostic use in EU and EEA countries and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas.

Learn more

Aiforia® Lymph Node Metastasis

Supports the detection and quantification of metastases of breast cancer, melanoma, and colorectal cancer in lymph nodes from whole slide images.

CE-IVD marked for diagnostic use in EU and EEA countries (IVDR) and for Research Use Only (RUO) and Performance Studies Only (PSO) in all other market areas.

Aiforia® Prostate Cancer Suite

Aiforia® Prostate Cancer Suite consists of AI models with an optimized interactive user interface that supports pathologists in Gleason grade grouping and identifying adverse histopathological features.

  • Aiforia® Prostate Cancer Gleason Grade Groups*
  • Aiforia® Prostate Cancer PNI*
  • Aiforia® Prostate Cancer G4 Cribriform*
  • Aiforia® Prostate Cancer HG-PIN

*CE-IVD marked for diagnostic use in EU and EEA countries. All other AI models are currently for Research Use Only (RUO) and for Performance Studies Only (PSO) in all market areas.

Learn more

Elevate diagnostic capabilities with Aiforia® Clinical Suites

ic_discover_pink

Complete AI-driven workflow

Aiforia’s solutions support the complete AI-driven workflow through an optimized combination of the worklist, interactive Clinical Viewer, a broad portfolio of quantitative AI models, and case-level reporting.

ic_wellbeing_pink

Comprehensive case-level review and reporting

Aiforia® Clinical Suites conveniently combine results from multiple AI models, WSIs, and stainings into a case-level view and report for first-read diagnostic support.

ic_our_ai-1_pink

Precise, transparent AI results

Aiforia takes accuracy beyond standard AI heatmaps by clearly marking the exact findings with detailed visual overlays directly on the digital slides, enabling easy visual confirmation at any magnification level. This approach empowers pathologists with both visual transparency and exact quantitative data, delivering actionable insights.

ic_automate-2_pink

Seamless integrations & flexible deployment

Aiforia offers seamless integration into existing laboratory systems, with publicly available API specifications. Customers can choose from different deployment options according to their needs. 

Hear from Aiforia's customers

Explore more >
Aiforias AI video interview_Dr. Johanna_thumbnail play button visual
AI stories by Aiforia users: interview with Dr. Johanna Palacios
Over 140 pathologists in Castile and León will be using Aiforia in their daily practice. We interviewed Dr. Johanna Palacios, a general surgical pathologist at the Burgos University Hospital in Spain, about their journey and experiences so far.
Aiforias AI video interview_Dr. Ilknur_thumbnail 1 play button visual
AI stories by Aiforia users: interview with Dr. Ilknur (Memorial Healthcare Group)
AP-HP Youtube thumbnail play button visual
Customer story: Aiforia's solutions at AP-HP
Aiforias AI video interview_Unibern_thumbnail play button visual
Industry-academia collaboration led to a CE-IVD marked AI solution: Aiforia and University of Bern

The benefits of AI in clinical diagnostics

 
Increased efficiency
Increased efficiency

Diagnose more patients in less time by unbinding yourself from time-consuming, manual tasks.

 

Advanced precision
Advanced precision

Improve diagnostic accuracy and be confident in your decision-making.

 

Improved consistency
Improved consistency

Reduce variability to standardize your sample review and ensure democratized patient care.

 

Statement on security

Aiforia Technologies holds information security to the highest standard. We hold several globally relevant quality and security certifications, so you can be sure your sensitive information is safe.

Learn more
Case studies, resources and more

AI for clinical diagnostics

Lung_PDL1_carousel_size

CASE STUDY

Southampton case study: AI-driven analysis of PD-L1 lung cancer

University Hospital Southampton is implementing Aiforia’s clinical PD-L1 lung cancer AI solution to assess PD-L1 staining in lung cancer specimens.

Read the article >

Memorial Hospital_carousel_size

CASE STUDY

Memorial Pathology case study: implementing AI in a private hospital setting

Memorial Pathology implemented Aiforia® Clinical Suites for breast, prostate, and PD-L1 lung to gain efficiency and accuracy in the routine workflow.

Read the article >

PD-L1_stock 1_resource_carousel_banner

WEBINAR

PD-L1 on the edge: cut-offs, cognitive bias & the case for AI in lung cancer pathology

This webinar takes you inside the real-world diagnostic pressure points of PD-L1 TPS testing in NSCLC. With insights drawn from clinical research, pathology practice, and oncology decision-making, we examine the human limits of PD-L1 scoring and how AI can sharpen clinical decisions.

Watch >

How did the Mayo Clinic choose a vendor for AI in pathology – carousel

BLOG POST

How did the Mayo Clinic choose a vendor for AI in pathology?

What to consider when choosing a vendor for AI in pathology? Learn how the Mayo Clinic evaluated platform providers based on six key criteria.

Read the article >

Digital pathology deployment in Veneto 8 steps to success_blog banner-1-1

BLOG POST

Digital pathology deployment in Veneto: 8 steps to success

What is required for pathology laboratories to go fully digital? Learn how the broadest public healthcare provider in the Veneto region did it.

Read the article >

Generic bg - AI duplicate-1

BLOG POST

5 reasons to use AI in clinical diagnostics

What additional benefit does AI bring to the digitized pathology workflow in clinical diagnostics? Read our article to find out.

Read the article >

 

Seeing is believing

Request a demo

Discover the power of AI for image analysis

Find out how to enhance your image analysis work in diagnostic pathology, preclinical studies, or medical research. The demo will be tailored based on your interests.

The demo will help you understand: 

  • How AI-assisted image analysis can increase efficiency, precision, and consistency in the pathology workflow.
  • The limitless possibilities Aiforia® Platform offers – both for research and clinical diagnostics – and the suitable use cases for your needs. 

We can either demonstrate Aiforia’s image analysis solutions on your own images or any of our 400+ application examples (i.e., neuron quantification, automated tumor grading, NASH analysis, etc.).

Fill in the form, and one of our experts will contact you shortly to schedule the time.
Regulatory note: Only certain Aiforia® Clinical AI models and the Aiforia® Clinical Suite Viewer are CE-IVD marked for diagnostic use in EU and EEA countries. In all other countries, the use is limited to Research Use Only, not for use in diagnostic procedures. Refer to the product information of each AI model for the regulatory status.